The results demonstrated that the decreased CXCL12 expression allowed for highly accurate BLCA diagnosis in both TCGA (AUC = 0.906) and GEO datasets (AUC = 0.930) (Fig. 1C). The gene discussed is CXCL12; the disease is bladder transitional cell carcinoma.